|
US6008230A
(en)
*
|
1995-10-16 |
1999-12-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinoline compounds as H+ -ATPases
|
|
GB9712761D0
(en)
*
|
1997-06-17 |
1997-08-20 |
Chiroscience Ltd |
Quinolines and their therapeutic use
|
|
US6262070B1
(en)
|
1998-11-04 |
2001-07-17 |
Darwin Discovery Ltd. |
Heterocyclic compounds and their therapeutic use
|
|
GB9824160D0
(en)
*
|
1998-11-04 |
1998-12-30 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
SI1212089T1
(sl)
|
1999-08-21 |
2006-08-31 |
Altana Pharma Ag |
Sinergisticna kombinacija roflumilasta in salmeterola
|
|
WO2001032658A1
(en)
*
|
1999-11-02 |
2001-05-10 |
Ajinomoto Co., Inc. |
Polyazanaphthalene compound and medicinal use thereof
|
|
JP4603646B2
(ja)
*
|
1999-11-15 |
2010-12-22 |
富士フイルムファインケミカルズ株式会社 |
新規なジピリジル誘導体
|
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
|
GB0003256D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
DE10035928A1
(de)
|
2000-07-21 |
2002-03-07 |
Asta Medica Ag |
Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
|
|
EP1310488A4
(en)
*
|
2000-08-09 |
2005-08-10 |
Mitsubishi Pharma Corp |
CONDENSED BICYCLIC AMIDE COMPOUNDS AND MEDICAL USES THEREOF
|
|
US6953774B2
(en)
|
2000-08-11 |
2005-10-11 |
Applied Research Systems Ars Holding N.V. |
Methods of inducing ovulation
|
|
JP2002300373A
(ja)
*
|
2001-03-30 |
2002-10-11 |
Minolta Co Ltd |
画像処理方法、画像処理装置、記録媒体及びプログラム
|
|
CA2447619A1
(en)
|
2001-05-23 |
2002-11-28 |
Tanabe Seiyaku Co., Ltd. |
A composition for accelerating bone fracture healing
|
|
WO2002094320A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Tanabe Seiyaku Co., Ltd. |
Therapeutic compositions for repairing chondropathy
|
|
DE60215178T2
(de)
|
2001-07-16 |
2007-08-23 |
Astrazeneca Ab |
Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase
|
|
EP1417204B1
(en)
*
|
2001-08-15 |
2006-01-18 |
E. I. du Pont de Nemours and Company |
Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
|
|
ES2293965T3
(es)
|
2001-12-14 |
2008-04-01 |
Laboratoires Serono Sa |
Metodo de inducir la ovulacion utilizando un modulador no polipeptidico de los niveles de camp.
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
SE0200920D0
(sv)
*
|
2002-03-25 |
2002-03-25 |
Astrazeneca Ab |
Novel compounds
|
|
ES2195785B1
(es)
*
|
2002-05-16 |
2005-03-16 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
AU2002950217A0
(en)
|
2002-07-16 |
2002-09-12 |
Prana Biotechnology Limited |
8- Hydroxy Quinoline Derivatives
|
|
ES2211344B1
(es)
*
|
2002-12-26 |
2005-10-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
TWI324150B
(en)
*
|
2003-02-28 |
2010-05-01 |
Novartis Ag |
Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt
|
|
JP2006522151A
(ja)
|
2003-04-01 |
2006-09-28 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
不妊症におけるホスホジエステラーゼ阻害剤
|
|
TWI324151B
(en)
*
|
2003-04-02 |
2010-05-01 |
Novartis Ag |
Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones
|
|
RU2350354C2
(ru)
*
|
2003-05-29 |
2009-03-27 |
Астразенека Аб |
ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ АНТАГОНИСТ Р2Х7 РЕЦЕПТОРА И ФАКТОР НЕКРОЗА ОПУХОЛИ α
|
|
US20070281931A1
(en)
*
|
2003-05-29 |
2007-12-06 |
Nigel Boughton-Smith |
Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
|
|
EP1644041A1
(en)
*
|
2003-05-29 |
2006-04-12 |
AstraZeneca AB |
A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
|
|
GB0312609D0
(en)
*
|
2003-06-02 |
2003-07-09 |
Astrazeneca Ab |
Novel compounds
|
|
SE0302139D0
(sv)
*
|
2003-07-28 |
2003-07-28 |
Astrazeneca Ab |
Novel compounds
|
|
SE0302192D0
(sv)
*
|
2003-08-08 |
2003-08-08 |
Astrazeneca Ab |
Novel compounds
|
|
CA2538591A1
(en)
*
|
2003-09-15 |
2005-03-31 |
Schering Corporation |
Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
|
|
SE0302488D0
(sv)
*
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
New combination
|
|
AU2004298486A1
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
DK2666481T3
(en)
*
|
2003-12-26 |
2019-02-25 |
Masatoshi Hagiwara |
A method for regulating the phosphorylation of SR protein and antiviral agents comprising an SR protein activity regulator as the active ingredient
|
|
EA010369B1
(ru)
|
2004-02-04 |
2008-08-29 |
Пфайзер Продактс Инк. |
Замещенные хинолиновые соединения
|
|
WO2005097058A2
(en)
*
|
2004-04-01 |
2005-10-20 |
F. Hoffmann-La Roche Ag |
Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones
|
|
PE20060241A1
(es)
*
|
2004-05-18 |
2006-04-01 |
Schering Corp |
2-quinolil-oxazoles sustituidos como inhibidores de pde4
|
|
ES2251866B1
(es)
*
|
2004-06-18 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
ES2251867B1
(es)
*
|
2004-06-21 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
GB0413960D0
(en)
*
|
2004-06-22 |
2004-07-28 |
Novartis Ag |
Organic compounds
|
|
WO2006002421A2
(en)
*
|
2004-06-24 |
2006-01-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
SA05260265A
(ar)
*
|
2004-08-30 |
2005-12-03 |
استرازينيكا ايه بي |
مركبات جديدة
|
|
AR051213A1
(es)
*
|
2004-10-12 |
2006-12-27 |
Actelion Pharmaceuticals Ltd |
1-(2-(4-bencil-4-hidroxi-piperidin-1-il)-etil)-3-(2-metil-quinolin-4-il)-urea como una sal sulfato cristalina
|
|
ATE517882T1
(de)
*
|
2004-10-19 |
2011-08-15 |
Hoffmann La Roche |
Chinolinderivate
|
|
SE0402925D0
(sv)
*
|
2004-11-30 |
2004-11-30 |
Astrazeneca Ab |
Novel Compounds
|
|
EP1917245A1
(de)
|
2005-08-21 |
2008-05-07 |
Abbott GmbH & Co. KG |
Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
|
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
US7678363B2
(en)
|
2005-08-26 |
2010-03-16 |
Braincells Inc |
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
|
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20090105272A1
(en)
*
|
2005-12-24 |
2009-04-23 |
Grootenhuis Peter D J |
Prodrugs of modulators of ABC transporters
|
|
AU2006332726B2
(en)
*
|
2005-12-28 |
2012-12-13 |
Vertex Pharmaceuticals Incorporated. |
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
KR100821649B1
(ko)
*
|
2006-01-24 |
2008-04-11 |
서울시립대학교 산학협력단 |
클리오퀴놀을 유효성분으로 포함하는 ＨＩＦ-1α 활성제
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
NZ574070A
(en)
*
|
2006-07-11 |
2011-12-22 |
Schering Corp |
Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
|
|
US20100056791A1
(en)
|
2006-09-01 |
2010-03-04 |
Yasushi Kohno |
Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CL2007003874A1
(es)
*
|
2007-01-03 |
2008-05-16 |
Boehringer Ingelheim Int |
Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
|
|
ES2306595B1
(es)
*
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
|
ES2320954B1
(es)
*
|
2007-03-02 |
2010-03-16 |
Laboratorio Almirall S.A. |
Nuevo procedimiento de preparacion de 3-metil-4-fenilisoxazolo (3,4-d)iridazin-7(6h)-ona.
|
|
ES2388454T3
(es)
*
|
2007-03-22 |
2012-10-15 |
Astrazeneca Ab |
Derivados de quinolina para el tratamiento de enfermedades inflamatorias
|
|
US9321730B2
(en)
|
2007-08-21 |
2016-04-26 |
The Hong Kong Polytechnic University |
Method of making and administering quinoline derivatives as anti-cancer agents
|
|
US8106073B2
(en)
|
2007-11-30 |
2012-01-31 |
Astrazeneca Ab |
Quinoline derivatives 057
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
AU2010226400B2
(en)
|
2009-03-20 |
2016-07-14 |
Vertex Pharmaceuticals Incorporated |
Process for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
JP2011042643A
(ja)
*
|
2009-07-24 |
2011-03-03 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
|
CA2796826A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bifunctional quinoline derivatives
|
|
AR081377A1
(es)
|
2010-05-10 |
2012-08-29 |
Gilead Sciences Inc |
Compuestos de pirazolopiridina bifuncionales
|
|
US20140275224A1
(en)
*
|
2010-11-05 |
2014-09-18 |
Regents Of The University Of Minnesota |
Cytosine deaminase modulators for enhancement of dna transfection
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
CN102603628B
(zh)
|
2010-12-22 |
2016-08-17 |
香港理工大学 |
作为抗癌试剂的喹啉衍生物
|
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
CA2865519C
(en)
|
2012-02-27 |
2018-01-02 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
|
|
CN103285373A
(zh)
*
|
2013-05-30 |
2013-09-11 |
苏州普罗达生物科技有限公司 |
肿瘤坏死因子-α多肽抑制剂制备及其应用
|
|
CN103254291B
(zh)
*
|
2013-05-30 |
2014-06-25 |
常州亚当生物技术有限公司 |
肿瘤坏死因子-α多肽抑制剂及其应用
|
|
SG10201704327RA
(en)
*
|
2013-10-14 |
2017-06-29 |
Eisai R&D Man Co Ltd |
Selectively substituted quinoline compounds
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|
|
RU2624906C2
(ru)
*
|
2015-12-22 |
2017-07-10 |
федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации |
Производные 2-хинальдинкарбоновой кислоты и их противогриппозная активность
|
|
WO2019053015A1
(en)
|
2017-09-13 |
2019-03-21 |
Syngenta Participations Ag |
MICROBIOCIDE DERIVATIVES OF QUINOLINE (THIO) CARBOXAMIDE
|
|
CN107812006A
(zh)
*
|
2017-11-13 |
2018-03-20 |
全椒先奇医药科技有限公司 |
一种治疗急性肾衰药物组合物及其应用
|